Heather Boerner’s October 2018 piece at NPR examined the fate of people who live without treatment for their HIV after they leave prison. The piece was pinned to a study published in PLOS One showing that people with HIV often are lost to care once they leave the monitoring and services provided in prison.
In her article, in addition to providing an in-depth perspective from several experts, Boerner also gave the reader the story of Bryan C. Jones, who had left a prison in Ohio and almost immediately ditched his HIV drugs because he knew they were no longer working. Continue reading
Sometimes you have to learn things the hard way to get them right the next time – even when you already know better and shouldn’t have made that rookie mistake in the first place.
That’s what this post is about: My haste in covering a story I already know a lot about led me to omit a crucial piece of reporting – checking for potential conflicts of interest. I hope others will learn from my experience and use the resources I provide below to avoid the same mistake. Continue reading
Photo: Len Bruzzese/AHCJWall Street Journal reporter John Carreyrou spoke about his award-winning investigation of Theranos at Health Journalism 2018.
The story about the fall of Theranos provides an important lesson for journalists about how we should be more diligent when reporting on the spin that companies use to promote themselves.
Last week, a federal grand jury returned an indictment against Elizabeth Holmes, the founder and former CEO of Theranos, and Ramesh “Sunny” Balwani, who served in various roles for the clinical laboratory testing company in Palo Alto, Calif. In an indictment unsealed Friday, the federal Department of Justice announced in a news release that Holmes and Balwani were alleged to have perpetrated multimillion dollar schemes designed to defraud patients, doctors and investors. Note that the release includes a link to a PDF of the indictment itself. Continue reading
Last year we drew your attention to a growing boom in health care podcasts. Time for an update.
Please note that this is partly crowdsourced – I don’t have time to listen to all of them! Email me your favorites, and I may add them to the next update. Items with a “*” are either additions from the first list, or have been updated. Also included are podcasts that may primarily focus on overall domestic policy but dip into health policy or public health topics often enough to be a worthwhile listen. So in no particular order: Continue reading
In a previous blog post about EurekAlert!, I described some advantages to using the service less often than many reporters new to the health beat often do. But that post didn’t address how you can start leaving those EurekAlert! email updates unopened in your inbox.
Here are several tips to help you become less dependent on EurekAlert!. Tip: These alternatives can result in adding email alerts to your inbox each day, so it may be worth setting up a dedicated email address for all the lists you’re on. Continue reading
When the EurekAlert! press release service was taken down on Sept. 13 after being hacked, there was a discussion about how much journalists rely on embargoes — and whether those standard practices should continue. A post at Embargo Watch succinctly summarized the pros and cons of abandoning the embargo system, leading to a robust dialogue in the comments section.
With EurekAlert! back up as of Oct. 3, it’s likely back to business as usual for those who relied on the service extensively. Continue reading